Ketamine for Addiction: How It Works, What to Expect, and the Risks You Should Know

Ketamine for Substance Use Disorders: A New Frontier in Treatment

Ketamine, long known as an anesthetic and more recently as a rapid-acting antidepressant, is emerging as a promising tool for treating substance use disorders—particularly alcohol, cocaine, and opioid addiction. Researchers believe its unique action on the brain's glutamate system, its ability to spur neuroplasticity, and the profound psychological experiences it can induce may help "reset" neural circuits hijacked by addiction.

Why Ketamine Might Help Addiction

  • Restoring brain connections: Ketamine boosts BDNF (brain-derived neurotrophic factor) and triggers synaptogenesis in the prefrontal cortex and hippocampus, reversing the atrophy caused by chronic stress and substance use.
  • Disrupting cue-driven cravings: It interferes with the reconsolidation of maladaptive memories—those powerful associations between drug cues (people, places, paraphernalia) and the urge to use.
  • Enhancing psychological flexibility: The dissociative and mystical-type experiences during treatment can foster insight, increase self-efficacy, and help patients reframe their relationship with substances.
  • Treating co-occurring depression: Ketamine's rapid antidepressant effect addresses the depression that often drives and sustains substance use.

Common Treatment Protocols (Off-Label/Research Settings)

  • IV ketamine: 0.5 mg/kg infused over 40 minutes, typically 1–2 times per week for 4–6 sessions (the most studied regimen).
  • Intramuscular (IM) or subcutaneous (SC): 0.5–0.75 mg/kg; offers faster administration and lower cost.
  • Intranasal esketamine (Spravato): FDA-approved for treatment-resistant depression; used off-label for SUD. Typical dosing: 56–84 mg twice weekly, then weekly.
  • Ketamine-assisted psychotherapy (KAP): Integration therapy sessions before, during, or after dosing—considered essential for making meaning of the experience and translating insights into lasting behavioral change.

What the Evidence Shows So Far

SubstanceEvidence Summary
AlcoholRandomized controlled trials show increased abstinence days, reduced heavy drinking, and decreased craving, especially when combined with KAP and IV ketamine.
CocaineSmall trials report reduced craving and use with IV ketamine plus cognitive-behavioral therapy.
OpioidsCase series suggest reduced withdrawal symptoms and improved retention in medication-assisted treatment; randomized trials are needed.
MethamphetaminePreclinical data only; human studies lacking.

Risks and Side Effects

  • Acute (during/shortly after infusion): Dissociation, elevated blood pressure and heart rate, nausea, dizziness, blurred vision—typically resolve within 1–2 hours.
  • Psychiatric: Transient anxiety, panic, or worsening of psychotic symptoms (patients with a history of psychosis are carefully screened out).
  • Chronic (with high-dose, frequent, non-medical use): Bladder inflammation (cystitis), liver toxicity, cognitive impairment, and dependence—rare in controlled therapeutic settings.
  • Contraindications: Uncontrolled hypertension, aneurysm, active psychosis, pregnancy, increased intracranial pressure.

Clinical Considerations for Safe, Effective Use

  • Treatment must occur in a licensed medical setting with continuous monitoring (blood pressure, heart rate, oxygen saturation, sedation level).
  • Integration psychotherapy is non-negotiable for SUD—the biological "reset" requires psychological scaffolding to consolidate gains.
  • Ketamine is not a standalone cure; it should be combined with medication for opioid use disorder (MOUD), CBT, contingency management, and peer support.
  • Cost: $400–$800 per IV session; often not covered by insurance for SUD indications.

Finding a Qualified Provider

  • American Society of Addiction Medicine (ASAM) provider directory.
  • Ketamine clinics with addiction psychiatry oversight.
  • Clinical trials via ClinicalTrials.gov (search "ketamine substance use").

Bottom Line

Ketamine is a promising adjunct for treatment-refractory substance use disorders, not a magic bullet. Rigorous protocols, integration therapy, and comprehensive, ongoing care are essential. Discuss with an addiction specialist to determine if it's appropriate for your situation.

Drug Addiction - Related Articles